DE60126332D1 - Wärmeformbare feste pharmazeutische zusammensetzung für die kontrollierte freigabe von ivabradin - Google Patents

Wärmeformbare feste pharmazeutische zusammensetzung für die kontrollierte freigabe von ivabradin

Info

Publication number
DE60126332D1
DE60126332D1 DE60126332T DE60126332T DE60126332D1 DE 60126332 D1 DE60126332 D1 DE 60126332D1 DE 60126332 T DE60126332 T DE 60126332T DE 60126332 T DE60126332 T DE 60126332T DE 60126332 D1 DE60126332 D1 DE 60126332D1
Authority
DE
Germany
Prior art keywords
ivabradine
pharmaceutical composition
formable
heat
controlled release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60126332T
Other languages
English (en)
Other versions
DE60126332T2 (de
Inventor
Patrick Wuthrich
Herve Rolland
Gilles Briault
Gerald Pichon
Francois Tharrault
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Publication of DE60126332D1 publication Critical patent/DE60126332D1/de
Application granted granted Critical
Publication of DE60126332T2 publication Critical patent/DE60126332T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60126332T 2000-12-26 2001-12-21 Wärmeformbare feste pharmazeutische zusammensetzung für die kontrollierte freigabe von ivabradin Expired - Lifetime DE60126332T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0017015 2000-12-26
FR0017015A FR2818552B1 (fr) 2000-12-26 2000-12-26 Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine
PCT/FR2001/004134 WO2002051387A1 (fr) 2000-12-26 2001-12-21 Composition pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine

Publications (2)

Publication Number Publication Date
DE60126332D1 true DE60126332D1 (de) 2007-03-15
DE60126332T2 DE60126332T2 (de) 2007-08-30

Family

ID=8858190

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60126332T Expired - Lifetime DE60126332T2 (de) 2000-12-26 2001-12-21 Wärmeformbare feste pharmazeutische zusammensetzung für die kontrollierte freigabe von ivabradin

Country Status (27)

Country Link
US (1) US20040028743A1 (de)
EP (1) EP1345594B1 (de)
JP (2) JP2004518665A (de)
KR (1) KR100542472B1 (de)
CN (1) CN1203844C (de)
AT (1) ATE352290T1 (de)
AU (1) AU2002228119B2 (de)
BR (1) BR0116548A (de)
CA (1) CA2432645A1 (de)
CY (1) CY1106390T1 (de)
CZ (1) CZ304587B6 (de)
DE (1) DE60126332T2 (de)
DK (1) DK1345594T3 (de)
EA (1) EA005814B1 (de)
ES (1) ES2280420T3 (de)
FR (1) FR2818552B1 (de)
HK (1) HK1060514A1 (de)
HU (1) HU229410B1 (de)
MX (1) MXPA03005840A (de)
NO (1) NO333776B1 (de)
NZ (1) NZ526406A (de)
PL (1) PL203835B1 (de)
PT (1) PT1345594E (de)
SI (1) SI1345594T1 (de)
SK (1) SK286413B6 (de)
WO (1) WO2002051387A1 (de)
ZA (1) ZA200304441B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2818552B1 (fr) * 2000-12-26 2003-02-07 Servier Lab Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine
FR2834896B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'ivabradine
US20060165790A1 (en) * 2003-06-27 2006-07-27 Malcolm Walden Multiparticulates
TWI357815B (en) * 2003-06-27 2012-02-11 Euro Celtique Sa Multiparticulates
GB2418854B (en) 2004-08-31 2009-12-23 Euro Celtique Sa Multiparticulates
FR2882553B1 (fr) 2005-02-28 2007-05-04 Servier Lab Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882556B1 (fr) 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
WO2010128525A2 (en) 2009-05-04 2010-11-11 Dinesh Shantilal Patel A formulation of ivabradine for treating the cardiovascular disease
PT2579860E (pt) 2010-06-14 2014-05-30 Ratiopharm Gmbh Composição farmacêutica que contém ivabradina com libertação modificada
CN101897682B (zh) * 2010-07-13 2012-02-15 石药集团欧意药业有限公司 一种伊伐布雷定或其可药用盐固体制剂及其制备方法
CN102908327B (zh) * 2011-08-05 2015-03-11 江苏恒瑞医药股份有限公司 伊伐布雷定或其可药用盐的缓释制剂
WO2015091992A1 (en) * 2013-12-20 2015-06-25 Synthon B.V. Pharmaceutical composition comprising amorphous ivabradine
EP3025705B8 (de) 2014-11-25 2018-11-28 Sanofi Ilaç Sanayi ve Ticaret Anonim Sirketi Stabile Ivabradinformulierungen
CN104398486B (zh) * 2014-12-08 2018-01-12 武汉武药科技有限公司 一种盐酸伊伐布雷定渗透泵控释片及其制备方法
EP3366282A1 (de) 2017-02-28 2018-08-29 Sanovel Ilac Sanayi ve Ticaret A.S. Feste orale pharmazeutische zusammensetzungen von ivabradin
KR20190001340A (ko) * 2017-06-27 2019-01-04 에리슨제약(주) 이바브라딘을 포함하는 서방성 약제학적 조성물 및 이의 제조방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
DE4138513A1 (de) * 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
WO1997008950A1 (en) * 1995-09-07 1997-03-13 Fuisz Technologies, Ltd. System for rendering substantially non-dissoluble bio-affecting agents bio-available
IL133420A (en) * 1997-08-26 2004-07-25 Aventis Pharma Inc Tablet-shaped pharmaceutical preparation containing a combination of piperidinoalkanol and antihistamines and reduces symptomatic congestion
US6673367B1 (en) * 1998-12-17 2004-01-06 Euro-Celtique, S.A. Controlled/modified release oral methylphenidate formulations
DE19901040A1 (de) * 1999-01-14 2000-07-20 Knoll Ag Arzneiformen mit gesteuerter Freisetzung, enthaltend gut wasserlösliche Wirkstoffe
FR2795326B1 (fr) * 1999-06-28 2001-08-31 Adir Composition pharmaceutique solide thermoformable a liberation controlee
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
FR2818552B1 (fr) * 2000-12-26 2003-02-07 Servier Lab Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine

Also Published As

Publication number Publication date
ZA200304441B (en) 2004-06-25
MXPA03005840A (es) 2003-09-10
CZ304587B6 (cs) 2014-07-23
ES2280420T3 (es) 2007-09-16
HU229410B1 (en) 2013-12-30
HK1060514A1 (en) 2004-08-13
NO333776B1 (no) 2013-09-16
KR20030064876A (ko) 2003-08-02
EP1345594B1 (de) 2007-01-24
NO20032737L (no) 2003-06-16
JP2004518665A (ja) 2004-06-24
HUP0302522A3 (en) 2007-09-28
EA200300667A1 (ru) 2003-12-25
PL361662A1 (en) 2004-10-04
HUP0302522A2 (hu) 2003-12-29
SI1345594T1 (sl) 2007-04-30
NO20032737D0 (no) 2003-06-16
EP1345594A1 (de) 2003-09-24
WO2002051387A8 (fr) 2004-05-13
US20040028743A1 (en) 2004-02-12
SK286413B6 (sk) 2008-09-05
CN1482901A (zh) 2004-03-17
DK1345594T3 (da) 2007-05-21
CA2432645A1 (fr) 2002-07-04
FR2818552B1 (fr) 2003-02-07
ATE352290T1 (de) 2007-02-15
PL203835B1 (pl) 2009-11-30
CY1106390T1 (el) 2011-10-12
SK9422003A3 (en) 2003-12-02
JP2010100641A (ja) 2010-05-06
PT1345594E (pt) 2007-04-30
EA005814B1 (ru) 2005-06-30
CZ20032020A3 (cs) 2003-11-12
AU2002228119B2 (en) 2006-04-27
NZ526406A (en) 2005-08-26
CN1203844C (zh) 2005-06-01
FR2818552A1 (fr) 2002-06-28
BR0116548A (pt) 2003-12-23
DE60126332T2 (de) 2007-08-30
WO2002051387A1 (fr) 2002-07-04
KR100542472B1 (ko) 2006-01-11

Similar Documents

Publication Publication Date Title
DE60126332D1 (de) Wärmeformbare feste pharmazeutische zusammensetzung für die kontrollierte freigabe von ivabradin
EA200000584A3 (ru) Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием
CY1109483T1 (el) Φαρμακευτικη συνθεση για την ελεγχομενη απελευθερωση παρακεταμολης
DK1861073T3 (da) Fremgangsmåde til fremstilling af calcium-kompositioner i en kontinuerlig fluid-bed
ATE551046T1 (de) Polymere duftkapseln und ihre herstellung
ATE252377T1 (de) Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff
EA200001201A3 (ru) Таблетка с основой, позволяющая осуществлять пролонгированное высвобождение триметазидина после введения оральным путем
PT1051158E (pt) Composicoes farmaceuticas sob a forma de microparticulas polimericas obtidas por extrusao e esferonizacao
BR0212931A (pt) Composição farmacêutica de liberação prolongada contendo metformina
IL152243A0 (en) Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
AU2003233579A8 (en) Synthesis of inorganic structures using templation and catalysis by self assembled repeat protein polymers
NZ526405A (en) Thermoformable solid pharmaceutical composition for the controlled release of perindopril
AR031970A1 (es) Composicion farmaceutica solida termoformable para la liberacion controlada de ivabradina
MXPA01008348A (es) Microcapsulas para la liberacion prolongada de farmacos.
HUP0104787A3 (en) Modification agents for anionic polymerisation and use thereof, as well as the produced polymers and use thereof
PT1499278E (pt) Forma de dosagem farmaceutica de libertacao imediata compreendendo tibolona polimorfa
BR0212254A (pt) Composição farmaceutica
MXPA02012456A (es) Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y materiales para su sintesis.
TH51132EX (th) แหวน
ES1049850U (es) Poste de parada de autobus.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition